Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients ; volume:9 ; number:4 ; day:21 ; month:10 ; year:2020 ; pages:1043-1053 ; date:12.2020
Infectious diseases and therapy ; 9, Heft 4 (21.10.2020), 1043-1053, 12.2020
- Urheber
-
Pizzuti, Adam G.
Murray, E. Yancy
Wagner, Jamie L.
Gaul, Derek A.
Bland, Christopher M.
Jones, Bruce M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-020-00347-w
- URN
-
urn:nbn:de:101:1-2021010118431441856583
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pizzuti, Adam G.
- Murray, E. Yancy
- Wagner, Jamie L.
- Gaul, Derek A.
- Bland, Christopher M.
- Jones, Bruce M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA
Bestatin in the treatment of chronic reoccurring bacterial infections of the skin
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
Correction to: Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
Bacterial cell-free metabolites-based zinc oxide nanoparticles for combating skin-causing bacterial infections
Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis
Intravenous Versus Oral Omadacycline or Linezolid for Acute Bacterial Skin and Skin Infections: A post hoc Analysis of the OASIS Trials
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
Limited evidence for diagnosing bacterial skin infections in older adults in primary care: systematic review
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA
Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA